Valuation: Incyte Corporation

Market Cap 25.29B 22.02B 20.84B 18.94B 35.38B 2,422B 35.56B 248B 96B 1,231B 94.99B 92.88B 3,940B P/E 2026 *
55.7x
P/E 2027 * 17.2x
Enterprise Value 21.06B 18.34B 17.36B 15.77B 29.46B 2,017B 29.61B 207B 79.94B 1,025B 79.1B 77.34B 3,281B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.08x
Free-Float
98.16%
Yield 2026 *
-
Yield 2027 * -
1 day+2.30%
1 week+3.52%
Current month+3.57%
1 month+3.34%
3 months+28.92%
6 months+35.45%
Current year+29.21%
1 week 119.97
Extreme 119.97
127.74
1 month 119.97
Extreme 119.97
130.8
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
25/8/26 Tax

EVP, Human Resources

-504 0.0002%
19/8/26 Sell

Chairperson

-10,801 0.0053%
12/8/26 Sell

Chairperson

-10,803 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
+2.30%+3.52%+50.50%+114.45% 25.29B
+1.92%-0.48%+34.83%-4.25% 77.35B
+1.81%+3.71%-12.06%-33.66% 59.58B
+8.55%+15.70%+532.28%+51.79% 58.14B
-0.92%-3.86%-12.36%+24.21% 47.62B
+1.21%+1.96%+2.31%+147.74% 45.34B
+1.41%+1.68%+51.20%-13.52% 31.92B
+2.18%-2.09%-0.10%+145.28% 20.88B
+1.46%+0.59%+59.67%+98.84% 15.64B
-1.45%-7.16%+31.52%+135.84% 13.35B
Average +1.77%-0.92%+73.78%+66.67% 39.51B
Weighted average by Cap. +2.38%+0.03%+92.89%+44.00%

Financials

2026 *2027 *
Net sales 5.94B 5.18B 4.9B 4.45B 8.31B 569B 8.35B 58.34B 22.56B 289B 22.32B 21.82B 926B 6.27B 5.46B 5.16B 4.69B 8.77B 600B 8.81B 61.51B 23.79B 305B 23.54B 23.01B 976B
Net income 466M 406M 384M 349M 652M 44.61B 655M 4.57B 1.77B 22.67B 1.75B 1.71B 72.58B 1.5B 1.3B 1.23B 1.12B 2.09B 143B 2.1B 14.69B 5.68B 72.81B 5.62B 5.49B 233B
Net Debt -4.23B -3.68B -3.49B -3.17B -5.92B -405B -5.95B -41.53B -16.06B -206B -15.89B -15.54B -659B -5.99B -5.22B -4.94B -4.49B -8.38B -574B -8.42B -58.82B -22.75B -292B -22.51B -22B -933B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
18/09/26 USD 127.62 +2.30% 1,452,907
16/09/26 USD 124.75 +2.47% 1,347,302
15/09/26 USD 121.74 -0.37% 1,564,077
14/09/26 USD 122.19 +0.59% 1,455,967
11/09/26 USD 121.47 -1.47% 1,425,198
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
124.75USD
Average target price
127.74USD
Spread / Average Target
+2.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!